We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+7.36%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
AUM
$22.7B
AUM Growth
+$1.75B
Cap. Flow
+$485M
Cap. Flow %
2.14%
Top 10 Hldgs %
16.1%
Holding
2,336
New
81
Increased
1,378
Reduced
820
Closed
49

Top Sells

Rank Stock Value
1
DCM
NTT DOCOMO, Inc.
DCM
+$65.5M
2
VR
Validus Hold Ltd
VR
+$13.7M
3
KYO
Kyocera Adr
KYO
+$11.8M
4
GE icon
GE Aerospace
GE
+$11.1M
5
XL
XL Group Ltd.
XL
+$10.3M

Sector Composition

Rank Sector Weight
1 Technology 18.84%
2 Financials 16.86%
3 Healthcare 14.01%
4 Consumer Discretionary 9.98%
5 Industrials 8.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PETS icon
1501
PetMed Express
PETS
$41.7M
$853K ﹤0.01%
25,834
-2,284
-8% -$85.4K
MMI icon
1502
Marcus & Millichap
MMI
$1.16B
$852K ﹤0.01%
24,550
+3,620
+17% +$137K
LBTYA icon
1503
Liberty Global Class A
LBTYA
$3.62B
$851K ﹤0.01%
29,419
-1,053
-3% -$29.4K
VRTU
1504
DELISTED
Virtusa Corporation
VRTU
$850K ﹤0.01%
15,817
-395
-2% -$21.5K
UHT
1505
Universal Health Realty Income Trust
UHT
$603M
$846K ﹤0.01%
11,369
+351
+3% +$24.7K
UFPI icon
1506
UFP Industries
UFPI
$4.9B
$843K ﹤0.01%
23,870
+283
+1% +$10.4K
VIPS icon
1507
Vipshop
VIPS
$7.37B
$840K ﹤0.01%
134,589
+20,077
+18% +$165K
VYX icon
1508
NCR Voyix
VYX
$1.14B
$837K ﹤0.01%
48,010
-5,558
-10% -$99K
IONS icon
1509
Ionis Pharmaceuticals
IONS
$8.6B
$836K ﹤0.01%
16,204
+1,203
+8% +$56.5K
MDCO
1510
DELISTED
Medicines Co
MDCO
$835K ﹤0.01%
27,909
-104
-0.4% -$3.92K
GEO icon
1511
The GEO Group
GEO
$4.13B
$834K ﹤0.01%
33,160
+1,973
+6% +$50.4K
NAV
1512
DELISTED
Navistar International
NAV
$834K ﹤0.01%
21,668
+325
+2% +$13.6K
SPXC icon
1513
SPX Corp
SPXC
$11B
$832K ﹤0.01%
24,983
-376
-1% -$13.2K
SYKE
1514
DELISTED
SYKES Enterprises Inc
SYKE
$831K ﹤0.01%
27,241
-514
-2% -$15.3K
GWPH
1515
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$829K ﹤0.01%
4,801
-16
-0.3% -$2.31K
ACH
1516
Accendra Health
ACH
$237M
$824K ﹤0.01%
49,858
-18,831
-27% -$320K
AEIS icon
1517
Advanced Energy
AEIS
$11.6B
$822K ﹤0.01%
15,919
+1,954
+14% +$113K
DORM icon
1518
Dorman Products
DORM
$3.98B
$822K ﹤0.01%
10,691
+91
+0.9% +$6.96K
DLPH
1519
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
$818K ﹤0.01%
26,087
-3,885
-13% -$154K
DF
1520
DELISTED
Dean Foods Company
DF
$818K ﹤0.01%
115,258
-226,318
-66% -$1.98M
VREX icon
1521
Varex Imaging
VREX
$472M
$817K ﹤0.01%
28,507
-702
-2% -$23.1K
SLAB icon
1522
Silicon Laboratories
SLAB
$7.17B
$816K ﹤0.01%
8,888
+1,473
+20% +$144K
EXLS icon
1523
EXL Service
EXLS
$5.14B
$815K ﹤0.01%
61,565
-1,520
-2% -$18.8K
WAIR
1524
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
$811K ﹤0.01%
72,091
-663
-0.9% -$7.93K
MWA icon
1525
Mueller Water Products
MWA
$3.95B
$810K ﹤0.01%
70,344
+2,718
+4% +$32.2K

Similar funds

Aperio Group's Q3 2018 Portfolio in Review

As of Q3 2018, Aperio Group held 2,336 positions worth $22.7B, up 8.4% from $20.9B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Aperio Group's Q3 2018 filing shows 81 new, 1,378 increased, 820 reduced and 49 closed positions. Its largest new stake was Equitable Holdings: 244,837 shares worth $5.25M. The largest sale was NTT DOCOMO, Inc., an estimated $65.5M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Aperio Group's largest Q3 2018 buy was Equitable Holdings: 244,837 shares worth $5.25M.
  • Aperio Group added most to Amazon in Q3 2018, an estimated $19M increase.
  • Aperio Group's biggest Q3 2018 reduction was GE Aerospace, cutting an estimated $11.1M.
  • Aperio Group fully exited NTT DOCOMO, Inc. in Q3 2018, selling an estimated $65.5M.
  • Aperio Group's ten largest holdings make up 16% of its $22.7B portfolio in Q3 2018.
  • Aperio Group opened 81 new positions and closed 49 in Q3 2018.
  • Aperio Group's portfolio value rose 8.4% quarter-over-quarter to $22.7B.

Based on Aperio Group's 13F filing for Q3 2018, filed 18 Oct 2018.